NovaBay Pharmaceuticals Inc. said it would sell $2.7 million worth of securities to certain non-U.S. institutional investors in a private placement.
The company is selling preferred stock, which will be convertible into common shares following stockholder approval, and warrants that are going to be exercisable for $1.15 each.
The placement will close by Aug. 13.
